Issued Patents All Time
Showing 25 most recent of 74 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12410171 | Tropomyosin receptor kinase (TRK) degradation compounds and methods of use | Jialiang Wang, Xiaoran HAN, Liqun CHEN, Chengwei Zhang | 2025-09-09 |
| 12404244 | Pan-KIT kinase inhibitor having quinoline structure and application thereof | Qingsong LIU, Yun Wu, Beilei Wang, ZiPing Q, Fengming ZOU +5 more | 2025-09-02 |
| 12351773 | Lubricious thermoplastic compounds and thermoplastic articles made therefrom | Qing Ge | 2025-07-08 |
| 12318398 | MST1 kinase inhibitor and use thereof | Qingsong LIU, Yun Wu, Wenliang Wang, Beilei Wang, Ziping Qi +4 more | 2025-06-03 |
| 12310963 | Pyrazole derivatives and use thereof | Qing Liu, Xi Li, Ao WANG, Feng Zou, Cheng-Yu Chen +8 more | 2025-05-27 |
| 12221448 | Selective PI3Kδ inhibitor and use thereof | Qingsong LIU, Xiaofei Liang, Feng Li, Ziping Qi, Zongru JIANG +5 more | 2025-02-11 |
| 12162876 | Indazole kinase inhibitor and use thereof | Qingsong LIU, Xuesong Liu, Beilei Wang, Cheng-Yu Chen, Ziping Qi +6 more | 2024-12-10 |
| 12115158 | Survivin-targeting anti-tumor agents and uses thereof | Jian Zhang, Mingji Dai | 2024-10-15 |
| 12115152 | Pan-RAF kinase inhibitor and use thereof | Qing Liu, Xi Li, Ao WANG, Zi Ping Qi, Qing Liu +6 more | 2024-10-15 |
| 12110295 | WD40 repeat domain protein 5 (WDR5) degradation/disruption compounds and methods of use | Jian Jin, Gang Wang, Xufen Yu, Dongxu Li | 2024-10-08 |
| 12103924 | Mitogen-activated protein kinase kinase (MEK) degradation compounds and methods of use | Jian Jin, Jianping Hu, Jieli Wei, Hyerin Yim, Md Kabir | 2024-10-01 |
| 12065442 | Tropomyosin receptor kinase (TRK) degradation compounds and methods of use | Liqun CHEN | 2024-08-20 |
| 11981684 | Macrocyclic compounds and uses thereof | Jingrong Jean Cui, Evan Rogers, Jane Ung, Jeffrey P. Whitten, Dayong Zhai +4 more | 2024-05-14 |
| 11969472 | Tropomyosin receptor kinase (TRK) degradation compounds and methods of use | Jialiang Wang, Xiaoran HAN, Liqun CHEN | 2024-04-30 |
| 11753688 | Biomarker for early diagnosis and preoperative assessment of pheochromocytoma/paraganglioma, and application thereof | Liang-Wei Wang, Jingyun MA | 2023-09-12 |
| 11602534 | Pyrimidine derivative kinase inhibitors | Qingsong LIU, Xiaofei Liang, Beilei Wang, Kailin Yu, Zongru JIANG +8 more | 2023-03-14 |
| 11541051 | Compositions and methods for treating CDK4/6-mediated cancer | Jian Jin, Xiaobao Yang, Yan Xiong, Poulikos Poulikakos, Zoi Karoulia +2 more | 2023-01-03 |
| 11472799 | Serine threonine kinase (AKT) degradation / disruption compounds and methods of use | Jian Jin, Ramon Parsons, Jia Xu, Xufen Yu | 2022-10-18 |
| 11286264 | Macrocyclic compounds and uses thereof | Jingrong Jean Cui, Evan Rogers, Jane Ung, Jeffrey P. Whitten, Dayong Zhai +4 more | 2022-03-29 |
| 11155563 | Macrocyclic compounds and uses thereof | Jingrong Jean Cui, Evan Rogers, Jane Ung, Jeffrey P. Whitten, Dayong Zhai +4 more | 2021-10-26 |
| 10975082 | Inhibitor of FLT3 kinase and use thereof | Qingsong LIU, Xixiang Li, Aoli WANG, Ziping Qi, Hong Wu +6 more | 2021-04-13 |
| 10793543 | Selective C-KIT kinase inhibitor | Qingsong LIU, Qiang Wang, Beilei Wang, Feiyang LIU, Shuang QI +11 more | 2020-10-06 |
| 10781214 | Kinase inhibitor against wild-type and mutant EGFR | Qingsong LIU, Xixiang Li, Aoli WANG, Hong Wu, Kailin Yu +7 more | 2020-09-22 |
| 10669238 | Irreversible bruton's tyrosine kinase inhibitor | Qingsong LIU, Qianmao Liang, Yongfei Chen, Cheng-Yu Chen, Aoli WANG +8 more | 2020-06-02 |
| 10647700 | EZH2 inhibitor and use thereof | Qingsong LIU, Fengchao Lv, Chen Hu, Wen-Liang Wang, Ao WANG +6 more | 2020-05-12 |